Biotech

Categories
LTP Special Column (244) Fintech (24) Blockchain / Digital Asset (8) AI (19) ESG (22) Mergers & Acquisitions / Cross-border Investment (8) Capital Market / Securities (249) General Corporate Affairs (164) Infrastructure Projects / Construction Laws (112) Telecommunications and Media (1) Trade Secret (18) Trademark (47) Patent (36) Copyright (79) Competition Law (82) Biotech (39) Energy (16) Media / Entertainment (57) Employment Law (129) Personal Data Protection (44) Arbitration / Litigation (340) Tax (58) Environmental Protection Law (8) PRC Investment and Legal Compliance (31) Other Areas (233)

February 2026

Alert

Key Points Analysis of the Regulations on the Administration of Clinical Research and Clinical Translational Application of New Biomedical Technologies (Mainland China)

Joyce Wen

Teresa Huang

February 2026

Alert
Enactment of the National Health Insurance Data Management Act (Taiwan)

Teresa Huang

Elesha Wang

September 2025

Alert
Series Articles of the Regenerative Medicine Dual Legislation (9) – The Final Step of Taiwan’s Regenerative Medicinal Products Act: Draft Announcement of the Regulations for Registration of Regenerative Medicinal Products

Teresa Huang

Oli Wong

David Hung

September 2025

Alert
Series Articles of the Regenerative Medicine Dual Legislation (8) – "Regulations for Regenerative Medicine Techniques to Determine Tissue and Human Cell Donor Suitability" and "Fee-charging Standards for the Review of Regenerative Medicine Applications and Advertisement Publication" Announced

Teresa Huang

Oli Wong

David Hung

June 2025

Alert
Series Articles of the Regenerative Medicine Dual Legislation (7) – Draft Regulations on Cell Processing and Cell Bank Licensing Announced: Regenerative Medicine Act Taking Shape (Taiwan)

Teresa Huang

Oli Wong

David Hung

June 2025

Alert
Series Articles of the Regenerative Medicine Dual Legislation (6) – Clarifying Donor Eligibility and Fee Standards: Supporting Regulations Under the Regenerative Medicine Products Act Released (Taiwan)

Teresa Huang

Oli Wong

David Hung

May 2025

Alert
Brief Introduction to the Evolution of Foreign Capital Access Policy Governing China's Human Stem Cell and Gene Therapy (CGT) and the Key Points of Enterprise Compliance Supervision

Joyce Wen

Teresa Huang

April 2025

Alert
The Ministry of Health and Welfare of Taiwan Issued the Operational Principles for the Temporary Payment of New Cancer Drugs

Teresa Huang

David Hung

April 2025

Series Articles of the Regenerative Medicine Dual Legislation (5) – Draft Announcement of Certain Subsidiary Regulations Under the Regenerative Medicine Act (Taiwan)

Teresa Huang

Oli Wong

David Hung

March 2025

Series Articles of the Regenerative Medicine Dual Legislation (4) – Draft Announcement of Certain Subsidiary Regulations Under the Regenerative Medicinal Products Act (Taiwan)

Teresa Huang

Oli Wong

David Hung
1 2 3 4 >

Tag Cloud